CureVac said on Sept. 14 the German biotech firm cancelled contract manufacturing deals for the company's experimental Covid-19 vaccine with two prospective partners, after rivals with...
On the heels of its announcement to amp up mRNA Covid-19 vaccine manufacturing in Africa, BioNTech announced it is considering putting vaccine manufacturing sites in Rwanda...
A universal vaccine has been described as the ‘holy grail’ – but how close are we to getting one?
Palantir Technologies (PLTR) represents one of the few pure plays on cybersecurity in the financial markets. Yet, the company is actually branching out into areas you...
The teams at Roche and Genentech are off and running at the FDA, with regulators accepting a quick pitch for what would be the first bispecific...
The problem we face going forward as a big world of diverse nations and communities all dealing with the Covid threat is the uneven access we...
Flushed with the success of its COVID-19 vaccine, BioNTech has pressed the accelerator on the development of shots The post BioNTech’s mRNA vaccine drive now includes...
Do these meme stocks have what it takes to outlast the current hype? The post 4 Top Meme Stocks To Watch This Week appeared first on...
By May 9, 2021 India accounted for 57 percent of new COVID-19 cases anywhere in the world. This phenomenon rippled through the interconnected economies of the...
The sketchy history of international efforts to control bioweapons suggests that nations will resist cooperative monitoring of gene hacking for medical research.
Following a manufacturing mistake that left Emergent BioSolutions with a botched batch of Johnson & Johnson’s Covid-19 vaccine, the company is facing a shareholder lawsuit accusing it of...
By Kristalina Georgieva When G-20 finance ministers and central bank governors gather in Venice this week, they can take inspiration from the city’s unbreakable spirit. As...
The pharmaceutical industry overall has been deeply opposed to waiving COVID-19 vaccine patents, but a historian of the industry explains that drug companies once opposed patents...
Supply chains, choke points, and 'just in time' manufacturing – where things went right and wrong during the pandemic.
Upwards of 60% of the world needs to be vaccinated to suppress COVID-19 – even with an extra billion doses, that target looks very far away.
Moderna is adding two new production lines at the company's rebuilt former Polaroid plant in Massachusetts to increase overall production capacity by 50 percent for its...
PREVENT-19 met a key exploratory endpoint of the study by showing 93.2% efficacy against both “variants of concern” (VoC) and “variants of interest (VoI). Variant data...
Upon regulatory approvals, Novavax said, it is on course to reach manufacturing capacity of 100 million doses per month by the end of the third quarter...
President Joe Biden is headed to Europe at the end of this week on the first foreign trip of his administration, for G-7, NATO, U.S.-EU, and...
Southwestern Energy (SWN) has reached a $2.7 billion deal to acquire Indigo Natural Resources. Under the terms of the agreement, the company will pay $400 million...
Biotechnology company Moderna Inc. (MRNA) has inked an additional drug substance manufacturing agreement with Lonza. Per the terms of the agreement, a new production line will...
Moderna Inc. said on June 1 the company had entered into an agreement with Thermo Fisher Scientific for manufacturing and packaging its Covid-19 vaccine, as the...
A deal on an intellectual property waiver for Covid-19 vaccines at the World Trade Organization (WTO) was no closer to acceptance on May 31 despite Washington's...
By Kristalina Georgieva, Gita Gopinath, and Ruchir Agarwal Many countries have stepped up in the global fight against the pandemic, as have institutions such as the...
United Nations Secretary-General Antonio Guterres called on May 12 for the need to double the capacity of Covid-19 vaccine production and for fairer redistribution of the...
Samsung BioLogics Co. Ltd. and Pfizer Inc. on May 12 denied a report that they were working together to produce in South Korea a Covid-19 vaccine...
Despite some public virtue signalling, the Canadian government is not doing all it can to improve global access to COVID-19 vaccines. Canada has yet to announce...
EU Urges US To Ramp Up COVID Vaccine Exports As Desperate Nations Turn To China In the latest edition of his substack newsletter "BIG, Matt Stoller...
The process will take months, if it's even approved. But just the threat of waiving intellectual property rights could spur faster action.
Various strategies are being pursued to boost worldwide vaccine coverage.